Table 3.
Sensitivity and specificity of procalcitonin for co-infections in COVID-19 patients.
| >0.25 ng/mL | >0.5 ng/mL | 1 ng/mL | |
|---|---|---|---|
| Sensitivity | 82% | 58% | 44% |
| Specificity | 47% | 61% | 71% |
| Positive Predictive Value | 13% | 13% | 13% |
| Negative Predictive Value | 96% | 94% | 93% |
Sensitivity and specificity of procalcitonin for co-infections in COVID-19 patients.
| >0.25 ng/mL | >0.5 ng/mL | 1 ng/mL | |
|---|---|---|---|
| Sensitivity | 82% | 58% | 44% |
| Specificity | 47% | 61% | 71% |
| Positive Predictive Value | 13% | 13% | 13% |
| Negative Predictive Value | 96% | 94% | 93% |